Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | 39.62%1.41B | 39.62%1.41B | 4.05%1.01B | 4.05%1.01B | -26.02%969.82M | -26.02%969.82M | 170.84%1.31B | 170.84%1.31B | -13.47%484M | -13.47%484M |
| -Cash and cash equivalents | 39.62%1.41B | 39.62%1.41B | 4.05%1.01B | 4.05%1.01B | -26.02%969.82M | -26.02%969.82M | 170.84%1.31B | 170.84%1.31B | -13.47%484M | -13.47%484M |
| Securities and investments | 2.87%3.5B | 2.87%3.5B | 21.70%3.4B | 21.70%3.4B | -5.33%2.8B | -5.33%2.8B | -2.61%2.95B | -2.61%2.95B | 67.84%3.03B | 67.84%3.03B |
| -Trading securities | 2.87%3.5B | 2.87%3.5B | 21.70%3.4B | 21.70%3.4B | -4.55%2.8B | -4.55%2.8B | -1.12%2.93B | -1.12%2.93B | 63.96%2.96B | 63.96%2.96B |
| -Short term investments | ---- | ---- | ---- | ---- | ---- | ---- | -65.70%24.09M | -65.70%24.09M | --70.22M | --70.22M |
| Derivative assets | --10.14M | --10.14M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Receivables | 431.77%152.47M | 431.77%152.47M | 30.85%28.67M | 30.85%28.67M | -72.88%21.91M | -72.88%21.91M | 82.53%80.78M | 82.53%80.78M | -19.06%44.26M | -19.06%44.26M |
| -Accounts receivable | 123.53%76K | 123.53%76K | -44.26%34K | -44.26%34K | 1.67%61K | 1.67%61K | 22.45%60K | 22.45%60K | -99.91%49K | -99.91%49K |
| -Other receivables | 432.14%152.39M | 432.14%152.39M | 31.06%28.64M | 31.06%28.64M | -72.93%21.85M | -72.93%21.85M | 82.60%80.72M | 82.60%80.72M | 3,659.18%44.21M | 3,659.18%44.21M |
| Deferred assets | -82.19%6.61M | -82.19%6.61M | -66.75%37.09M | -66.75%37.09M | 285.79%111.54M | 285.79%111.54M | --28.91M | --28.91M | ---- | ---- |
| Other assets | -18.83%418K | -18.83%418K | -9.97%515K | -9.97%515K | 0.70%572K | 0.70%572K | 32.09%568K | 32.09%568K | 25.00%430K | 25.00%430K |
| Total assets | 13.42%5.08B | 13.42%5.08B | 14.83%4.48B | 14.83%4.48B | -10.85%3.9B | -10.85%3.9B | 22.84%4.37B | 22.84%4.37B | 41.72%3.56B | 41.72%3.56B |
| Liabilities | ||||||||||
| Derivative product liabilities | -32.76%1.84M | -32.76%1.84M | -66.00%2.73M | -66.00%2.73M | 660.04%8.03M | 660.04%8.03M | -68.13%1.06M | -68.13%1.06M | 20,606.25%3.31M | 20,606.25%3.31M |
| Payables | 39.64%1.9B | 39.64%1.9B | 25.61%1.36B | 25.61%1.36B | -39.68%1.08B | -39.68%1.08B | 34.67%1.8B | 34.67%1.8B | 76.60%1.33B | 76.60%1.33B |
| -Accounts payable | 42.33%1.81B | 42.33%1.81B | 34.68%1.27B | 34.68%1.27B | -45.42%945.12M | -45.42%945.12M | 42.54%1.73B | 42.54%1.73B | 60.85%1.21B | 60.85%1.21B |
| -Other payable | 1.10%89.82M | 1.10%89.82M | -36.07%88.84M | -36.07%88.84M | 111.98%138.96M | 111.98%138.96M | -45.23%65.55M | -45.23%65.55M | 28,601.20%119.68M | 28,601.20%119.68M |
| Current deferred liabilities | ---- | ---- | ---- | ---- | ---- | ---- | 717.42%83.82M | 717.42%83.82M | --10.25M | --10.25M |
| Non current deferred liabilities | 6.77%81.18M | 6.77%81.18M | 118.96%76.03M | 118.96%76.03M | --34.72M | --34.72M | ---- | ---- | --117.38M | --117.38M |
| Other liabilities | 1.35%1.13B | 1.35%1.13B | 15.21%1.12B | 15.21%1.12B | 20.02%968.11M | 20.02%968.11M | 54.78%806.6M | 54.78%806.6M | -15.46%521.11M | -15.46%521.11M |
| Total liabilities | 21.88%3.11B | 21.88%3.11B | 22.00%2.56B | 22.00%2.56B | -22.08%2.09B | -22.08%2.09B | 35.34%2.69B | 35.34%2.69B | 44.78%1.99B | 44.78%1.99B |
| Shareholders'equity | ||||||||||
| Share capital | 1.48%1.28B | 1.48%1.28B | 1.33%1.26B | 1.33%1.26B | 1.14%1.24B | 1.14%1.24B | 1.04%1.23B | 1.04%1.23B | -5.53%1.22B | -5.53%1.22B |
| -common stock | 1.48%1.28B | 1.48%1.28B | 1.33%1.26B | 1.33%1.26B | 1.14%1.24B | 1.14%1.24B | 1.04%1.23B | 1.04%1.23B | -5.53%1.22B | -5.53%1.22B |
| Retained earnings | 0.00%-146.49M | 0.00%-146.49M | 0.00%-146.49M | 0.00%-146.49M | 0.00%-146.49M | 0.00%-146.49M | 0.00%-146.49M | 0.00%-146.49M | 0.00%-146.49M | 0.00%-146.49M |
| Gains losses not affecting retained earnings | 2.85%832.37M | 2.85%832.37M | 14.22%809.29M | 14.22%809.29M | 17.41%708.54M | 17.41%708.54M | 19.50%603.46M | 19.50%603.46M | --504.98M | --504.98M |
| Total stockholders'equity | 2.17%1.96B | 2.17%1.96B | 6.50%1.92B | 6.50%1.92B | 7.07%1.8B | 7.07%1.8B | 7.06%1.69B | 7.06%1.69B | 38.03%1.57B | 38.03%1.57B |
| Total equity | 2.17%1.96B | 2.17%1.96B | 6.50%1.92B | 6.50%1.92B | 7.07%1.8B | 7.07%1.8B | 7.06%1.69B | 7.06%1.69B | 38.03%1.57B | 38.03%1.57B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |